NCT01114126View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Neu-P11 in Subjects With Primary Insomnia

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

February 28, 2011

Study Completion Date

April 30, 2011

Conditions
Insomnia
Interventions
DRUG

Neu-P11

comparison of different dosages of drug

DRUG

Neu-P11 placebo

comparison of different dosages

Trial Locations (1)

68250

Centre hospitallier de Rouffach, Rouffach

Sponsors
All Listed Sponsors
lead

Neurim Pharmaceuticals Ltd.

INDUSTRY

NCT01114126 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Neu-P11 in Subjects With Primary Insomnia | Biotech Hunter | Biotech Hunter